After Alzheimer's, vascular dementia is the second-most common type of dementia. Following more than a decade of development in the lab, researchers are preparing to evaluate a novel peptide in humans.
For Moses Foiryolo, KEYS served as a foundational platform to learn more about his research interests and what he wanted to become.
A team of University of Arizona engineers led by Minkyu Kim will hide lifesaving drugs in synthetic cell-like carriers to reduce side effects.
U of A researchers found that a group of proteins involved in neuronal development was overrepresented in the umbilical cord blood of about one-third of babies born small for gestational age.
A study published in The New England Journal of Medicine found no improvement with azithromycin in young children, calling into question a common practice for treating severe wheezing.
Two scientists combine complementary strengths in RNA biology and aging neuron research to advance new approaches in studying ALS, supported by the University of Arizona BIO5 Institute.
Chandrasekaran “Arun” Sambamurthy at the University of Arizona studies how the parasite Toxoplasma survives inside the human brain, research shaped in part by the BIO5 Postdoctoral Fellowship.
University of Arizona researchers released the first four years of data from a nationwide study on precision aging, ushering in a new era of discovery for brain health and longevity.
The center was established in 1989 and has been continuously funded by the National Institutes of Health since 1997.